This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
post featured image
Both the Clinical Trials Coordination Group (CTCG) and the Portuguese National Authority of Medicines and Health Products (INFARMED) have...
post featured image
The Portuguese National Authority for Medicines and Health Products (“INFARMED”) and the Portuguese Environment Agency (“APA”) issued a...
post featured image
The Portuguese National Authority for Medications and Health Products (INFARMED) issued a bulletin on the topic of the usage of cannabis...
post featured image
The 31st January marked the day both the EU Clinical Trials Regulation (Regulation (EU) No 534/2014 – “CTR”), and the framework for the...
post featured image
Ordinance no. 14/2022, dated 5 January, alters the framework on the authorisation for activities relating to the growing, manufacture,...
post featured image
Ordinance no. 280/2021, dated 3 December (entering into force on December 4, 2021) creates an exceptional criterion to be used in the...
post featured image
Countries and industries have been progressively setting ‘net zero’ targets, adapting legislation and activities to move towards a...
post featured image
Portugal initiated the 2015/1535 notification procedure of the decree-law establishing the rules applicable to the reprocessing and...